FGFR2 amplification has prognostic significance in gastric cancer: results from a large international multicentre study
Su, X, Zhan, P, Gavine, P R, Morgan, S, Womack, C, Ni, X, Shen, D, Bang, Y-J, Im, S-A, Ho Kim, W, Jung, E-J, Grabsch, H I, Kilgour, E
Published in British journal of cancer (18.02.2014)
Published in British journal of cancer (18.02.2014)
Get full text
Journal Article
HER2, MET and FGFR2 oncogenic driver alterations define distinct molecular segments for targeted therapies in gastric carcinoma
Liu, Y J, Shen, D, Yin, X, Gavine, P, Zhang, T, Su, X, Zhan, P, Xu, Y, Lv, J, Qian, J, Liu, C, Sun, Y, Qian, Z, Zhang, J, Gu, Y, Ni, X
Published in British journal of cancer (04.03.2014)
Published in British journal of cancer (04.03.2014)
Get full text
Journal Article
Tumour cell responses to new fibroblast growth factor receptor tyrosine kinase inhibitors and identification of a gatekeeper mutation in FGFR3 as a mechanism of acquired resistance
Chell, V, Balmanno, K, Little, A S, Wilson, M, Andrews, S, Blockley, L, Hampson, M, Gavine, P R, Cook, S J
Published in Oncogene (20.06.2013)
Published in Oncogene (20.06.2013)
Get full text
Journal Article